Dynamic List Information
Dynamic List Data
Study Title
EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Sponsor Name
NovoCure GmbH
NCT Number
NCT04471844
IDE Number
G200113
CMS Approval Date
2020-10-01
Clinical Trial Link
Category
B